Polycythemia and Thrombocytosis

Prim Care. 2016 Dec;43(4):589-605. doi: 10.1016/j.pop.2016.07.011.

Abstract

Myeloproliferative neoplasms (MPNs) are diseases of excess cell proliferation from bone marrow precursors. Two classic MPNs, polycythemia vera (PV) and essential thrombocytosis (ET), are conditions of excess proliferation of red blood cells and platelets, respectively. Although PV and ET involve different cells in the myeloid lineage, their clinical presentations have shared features, consistent with overlapping mutations in growth factor signaling. The management of both diseases involves minimizing the risk of thrombotic and hemorrhagic complications. Both PV and ET can progress to myelofibrosis or acute myeloid leukemia, portending a poor prognosis. MPNs can also present as primary myelofibrosis.

Keywords: Essential thrombocytosis; JAK2 mutation; Myelofibrosis; Myeloproliferative neoplasms; Polycythemia vera.

Publication types

  • Review

MeSH terms

  • Diagnosis, Differential
  • Disease Management
  • Disease Progression
  • Hematologic Tests
  • Humans
  • Polycythemia / diagnosis*
  • Polycythemia / pathology
  • Polycythemia / therapy*
  • Primary Health Care*
  • Prognosis
  • Thrombocytosis / diagnosis*
  • Thrombocytosis / pathology
  • Thrombocytosis / therapy*